Cadila Healthcare completes USFDA inspection at Moraiya facility

10 Feb 2018 Evaluate

Cadila Healthcare has successfully completed the US Food and Drug Administration (USFDA) inspection at its Moraiya facility. USFDA had inspected the Moraiya facility from February 5 to February 9, 2018.  At the end of the inspection, no observation (483) is issued.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

894.95 -12.65 (-1.39%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.95
Dr. Reddys Lab 1209.45
Cipla 1466.15
Zydus Lifesciences 894.95
Lupin 2181.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×